Publicaciones (28) Publicaciones en las que ha participado algún/a investigador/a

2022

  1. A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment

    Neuropsychiatric Disease and Treatment, Vol. 18, pp. 965-976

  2. A mi amigo Enrique Reig

    MPJ Multidisciplinary Pain Journal, Núm. 1

  3. Anomalías congénitas y patología inflamatoria de la mama

    Obstetricia y ginecología (Elsevier), pp. 448-453

  4. Association between sexual satisfaction and resilience in premenopausal women

    Revista de Obstetricia y Ginecologia de Venezuela, Vol. 82, Núm. 3, pp. 322-328

  5. Benefits of SGLT2i for the Treatment of Heart Failure Irrespective of Diabetes Diagnosis: A State-of-the-Art Review

    Diabetes Therapy, Vol. 13, pp. 19-34

  6. Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer Patients*

    British Journal of Dermatology, Vol. 187, Núm. 6, pp. 962-969

  7. Delphi Consensus on Therapeutic Strategies and Health Prevention of hypovitaminosis D

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 4, pp. 115-124

  8. Diagnosis of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors

    JAMA Dermatology

  9. Effective Overall Glycaemic Control with Fast-Acting Insulin Aspart Across Patients with Different Baseline Characteristics: A Post Hoc Analysis of the Onset 9 Trial

    Diabetes Therapy, Vol. 13, Núm. 4, pp. 761-774

  10. European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task force ‘Dermatology for cancer patients’ position statement

    Journal of the European Academy of Dermatology and Venereology, Vol. 36, Núm. 3, pp. 332-350

  11. Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update)

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 5-12

  12. Glycaemic variability in patients with type 2 diabetes mellitus treated with dulaglutide, with and without concomitant insulin: Post hoc analyses of randomized clinical trials

    Diabetes, Obesity and Metabolism, Vol. 24, Núm. 4, pp. 631-640

  13. Guidelines on the management of mineral and bone metabolism disorders during pregnancy and lactation

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 7, pp. 530-539

  14. Histopathology of Dermatologic Complications of Tattoos

    American Journal of Dermatopathology, Vol. 44, Núm. 9, pp. 632-649

  15. Long-term use of ospemifene in clinical practice for vulvo-vaginal atrophy: end results at 12 months of follow-up

    Gynecological Endocrinology, Vol. 38, Núm. 7, pp. 577-582

  16. Patología benigna de la mama

    Obstetricia y ginecología (Elsevier), pp. 454-459

  17. Post-Myocardial Infarction Risk Prediction: Does Ventricular Shape Matter?

    JACC: Cardiovascular Imaging

  18. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

    European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301

  19. Reply to Calcifediol Is Not Superior to Cholecalciferol in Improving Vitamin D Status in Postmenopausal Women

    Journal of Bone and Mineral Research

  20. Results of a Hepatitis C Micro-Elimination Program in Two Addiction Centers Among Subjects With Substance Use Disorder

    Substance Abuse: Research and Treatment, Vol. 16